好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2007 Annual Meeting | Poster Session 07

Thursday 05/03/07
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Autonomic Disorders, Child Neurology/Developmental Neurobiology, Headache, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neurogenetics and Gene Therapy
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - Diagnostic Value of Lumbar Puncture in Young Infants Presenting with Possible New-Onset Seizures
11:30 AM - 02:30 PM Abstract 002 - Distal Truncation of KCC3 in HMSN/ACC Associated with Epileptiform Abnormalities
11:30 AM - 02:30 PM Abstract 003 - Adaptive Motor Decisions in Hemiplegic Children
11:30 AM - 02:30 PM Abstract 004 - Long-Term Follow up of Children with Guillain-Barr[eacute] Syndrome Associated with Corticospinal Tract Involvement
11:30 AM - 02:30 PM Abstract 005 - Efficacy and Tolerability of Cyproheptadine in the Prophylactic Treatment of Pediatric Migraine
11:30 AM - 02:30 PM Abstract 006 - Understanding Disability in Children with Tourette Syndrome
11:30 AM - 02:30 PM Abstract 007 - Is There Always Bradycardia during Tilt-Induced Neurally Mediated Syncope?
11:30 AM - 02:30 PM Abstract 008 - Postural Tachycardia Syndrome with Asystole on Head-Up Tilt Test
11:30 AM - 02:30 PM Abstract 009 - Postural Tachycardia Syndrome Fails Cardiac Abalation Therapy
11:30 AM - 02:30 PM Abstract 010 - Cardiovagal and Cardiac Sympathetic Coactivation during the Valsalva Maneuver
11:30 AM - 02:30 PM Abstract 011 - Decreased Cardiac 123I-MIBG Uptake in Sporadic Late-Onset Familial Amyloid Polyneuropathy Type I (TTR Met 30) Patients without Signs or Symptoms of Cardiovascular Autonomic Involvement
11:30 AM - 02:30 PM Abstract 012 - Assessment for Dysautonomia in Patients with Neurologic Symptoms Following LYMErix Vaccination
11:30 AM - 02:30 PM Abstract 013 - Distal Sudomotor Abnormalities in Postural Tachycardia Syndrome: Evidence for a Neuropathic Etiology?
11:30 AM - 02:30 PM Abstract 014 - QDIRT: Quantitative Direct Testing of Sudomotor Function
11:30 AM - 02:30 PM Abstract 015 - Phantom Sweating - A Novel Autonomic Paresthesia
11:30 AM - 02:30 PM Abstract 016 - Cognitive Functions in MSA-P and MSA-C Patients
11:30 AM - 02:30 PM Abstract 017 - Dysfunction of the Pupillary Light Reflex in Experimental Autoimmune Autonomic Neuropathy
11:30 AM - 02:30 PM Abstract 018 - Clinical, Biochemical and Genetic Features in Muscle Phosphofructokinase Deficiency
11:30 AM - 02:30 PM Abstract 019 - Pilot Trial of Ramipril in McArdle Patients
11:30 AM - 02:30 PM Abstract 020 - Variant McArdle Disease: Novel Splice Site Mutations Preserving Minimal Residual Glycogenolysis Ameliorate the Phenotype
11:30 AM - 02:30 PM Abstract 021 - Two Novel Mutations in the CLCN1 Gene of Myotonia Congenita
11:30 AM - 02:30 PM Abstract 022 - The Nondystrophic Myotonias: Genotype-Phenotype Correlation and Longitudinal Study. Clinical Phenotype Characterization
11:30 AM - 02:30 PM Abstract 023 - Interactiive Voice Response Diary and Objective Myotonia Measurements as Endpoints for Clinical Trials in Nondystrophic Myotonia
11:30 AM - 02:30 PM Abstract 024 - Physical and Mental Perception of Quality of Life in Patients with Myotonic Dystrophies: Correlation between Objective and Functional Measures of Muscle Disability, Cognitive, Behavioral and 好色先生al Aspects
11:30 AM - 02:30 PM Abstract 027 - Oculomotor Involvement in Myotonic Dystrophy Type 2 (DM2)
11:30 AM - 02:30 PM Abstract 028 - Phenotypical Spectrum of DOK-7 Mutations in Congenital Myasthenic Syndromes (CMS)
11:30 AM - 02:30 PM Abstract 029 - MuSK Antibody Positive Myasthenia Gravis: Response to Treatment in 31 Patients
11:30 AM - 02:30 PM Abstract 030 - Clinical Findings in MuSK-Antibody Positive Myasthenia Gravis
11:30 AM - 02:30 PM Abstract 031 - Are Immunosupresors as Effective in MuSK+MG as in AChR+MG Patients?: Evaluation of 150 Myasthenic Patients Treated with the Same Protocol.
11:30 AM - 02:30 PM Abstract 032 - Otoacoustic Emission Analysis Is a New, Simple, and Noninvasive Diagnostic Method for Ocular Myasthenia Gravis
11:30 AM - 02:30 PM Abstract 033 - Myasthenic Tongue: Fatigue and Morphological Changes
11:30 AM - 02:30 PM Abstract 034 - Predictors of Extubation Outcome in Myasthenic Crisis
11:30 AM - 02:30 PM Abstract 035 - Methotrexate for Treatment of Mysthenia Gravis
11:30 AM - 02:30 PM Abstract 036 - Parkinsonism with Progressive External Ophthalmoplegia from a Mutation in Twinkle, a Mitochondrial DNA Helicase
11:30 AM - 02:30 PM Abstract 037 - Nodular Infiltrates Serving as Sites of B-Cell Maturation in the Muscle of Patients with Inclusion Body Myositis
11:30 AM - 02:30 PM Abstract 038 - Detection of Autoantibodies by RNA Immunoprecipitation in Muscular Dystrophy: Utility on a Diagnosis of Myositis
11:30 AM - 02:30 PM Abstract 039 - Congenital Neuromuscular Disease with Uniform Type 1 Fiber Due to RYR1 Mutations
11:30 AM - 02:30 PM Abstract 040 - Homozygous Deletions of M-Line Titin Cause a Novel Early-Onset, Recessive Myopathy with Fatal Cardiomyopathy: "The Salih Congenital Muscular Dystrophy (CMD)" Phenotype
11:30 AM - 02:30 PM Abstract 041 - Myostatin Null Mice Have Less Muscle Atrophy in Response to Denervation Than Wild-Type Mice
11:30 AM - 02:30 PM Abstract 042 - Centronuclear Myopathy, Axonal Polyneuropathy, and Mental Retardation in a Large Family with a Novel Mutation in the Dynamin 2 Gene
11:30 AM - 02:30 PM Abstract 043 - Expression of Akt, GSK-3[beta], FOXO-1, and NF[kappa]B in Human Quadriceps Muscles with Neurogenic Atrophy
11:30 AM - 02:30 PM Abstract 044 - T-Cap Knockdown by RNA Interference Inhibits Myogenic Regulatory Factors in C2C12 Cells
11:30 AM - 02:30 PM Abstract 046 - Biased Usage of the T-Cell-Receptor (TCR) b-Chain-Variable-Region (Vb) of CD4+ Peripheral-Blood-Lymphocytes (PBL) in Patients with Stiff Person Syndrome (SPS)
11:30 AM - 02:30 PM Abstract 047 - Association Analysis of the MAPT H1 Haplotype and Subhaplotypes in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 048 - Identification of a Biomarker in Huntington Disease with Plasma NMR Spectroscopy Following Investigation of Weight Loss at Early Stages of the Disease
11:30 AM - 02:30 PM Abstract 050 - Comprehensive Analysis of Causative and Related Genes for ALS Using a High Throughput DNA Microarray-Based Resequencing System
11:30 AM - 02:30 PM Abstract 051 - Genotype-Phenotype Correlation in Mitochondrial Optic Neuropathies
11:30 AM - 02:30 PM Abstract 052 - Mitochondrial Coupling Defect in Fibroblasts from Patients with Mfn2-Related Charcot-Marie-Tooth Type 2a
11:30 AM - 02:30 PM Abstract 053 - Development of a Potent Viral Based Therapeutic for Alpha-Sarcoglycan Deficiencies
11:30 AM - 02:30 PM Abstract 054 - Fine-Mapping and Candidate Gene Sequencing of the Chromosome 9p Locus of ALS/FTD
11:30 AM - 02:30 PM Abstract 055 - Novel ROBO3 Mutations in Four Tunisian Families with Horizontal Gaze Palsy with Progressive Scoliosis
11:30 AM - 02:30 PM Abstract 056 - Comprehensive Analysis of the LRRK2 Gene in Japanese Patients with Parkinson's Disease
11:30 AM - 02:30 PM Abstract 057 - Subclinical Dysfunction of Cochlea and Cochlear Efferents in Migraine: An Otoacoustic Emission Study
11:30 AM - 02:30 PM Abstract 058 - The Dopaminergic A11 Cell Group Inhibits Nociceptive Transmission in the Trigeminal Nucleus Caudalis
11:30 AM - 02:30 PM Abstract 059 - Abnormal MRI Scan T2 High Intensity Signal Correlates with Gastric Emptying Delay and Treatment Responsiveness in Migraine Patients
11:30 AM - 02:30 PM Abstract 060 - Association between Polymorphisms and Haplotypes of the HCRTR2 Gene and Cluster Headache
11:30 AM - 02:30 PM Abstract 061 - Lack of Association between NOTHC4 Gene and Migraine
11:30 AM - 02:30 PM Abstract 062 - Is GABRE Gene at Xq28 Chromosome the X-Linked Migraine Gene?
11:30 AM - 02:30 PM Abstract 063 - Genetic Association Analysis of the GABA-A Receptor Gene Cluster at 15q in Migraine
11:30 AM - 02:30 PM Abstract 064 - MK-0974 Oral CGRP Antagonist Inhibits Capsaicin-Induced Increase in Dermal Microvascular Blood Flow
11:30 AM - 02:30 PM Abstract 065 - Two Cases of Chronic Cluster Headache Treated Successfully with Hypothalamic Deep Brain Stimulation
11:30 AM - 02:30 PM Abstract 066 - Degradation of Endocannabinoids in Chronic Migraine and Medication Overuse Headache
11:30 AM - 02:30 PM Abstract 067 - Statins Reduce Neurofibrillary-Tangles (NFT) Burden in a Transgenic (Tg) Mouse Model for Tauopathy and for Alzheimer's-Disease (AD)
11:30 AM - 02:30 PM Abstract 068 - When To Consider a Diagnosis of Genetic Prion Disease
11:30 AM - 02:30 PM Abstract 069 - Abnormal Progranulin Immunoexpression Precedes Tau Pathology in Preclinical Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 070 - Cervical Cord Is Vulnerable to Aging: A Diffusion-Tensor MRI Study
11:30 AM - 02:30 PM Abstract 071 - Tau and [alpha]-Synuclein Neurites Correlate with Synaptophysin Loss in Dementia with Lewy Bodies
11:30 AM - 02:30 PM Abstract 072 - Prevalence of Apo E - e2 Allele in Different Kinds of Dementia
11:30 AM - 02:30 PM Abstract 073 - Interactions of White Matter Lesions and APOE-[epsilon]4 in the Development of Alzheimer Disease
11:30 AM - 02:30 PM Abstract 074 - Chronic Nasal Administration of a Proteosome-Based Adjuvant Prevents B-Amyloid Accumulation Given at Early Stages in a Mouse Model of Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 075 - Heme Oxygenase-1/Sterol Interactions in Alzheimer Disease
11:30 AM - 02:30 PM Abstract 076 - Genetics of ALS-FTD
11:30 AM - 02:30 PM Abstract 077 - Poly (ADP-Ribose) Polymerase-1 Genetic Variants Modify the Risk for Alzheimer and Parkinson Disease
11:30 AM - 02:30 PM Abstract 078 - Interaction of Aromatase and Estrogen Receptor-Alpha Genes with Butyrylcholinesterase Gene Modulates Alzheimer's Disease Risk
11:30 AM - 02:30 PM Abstract 079 - Heme Oxygenase-1: Transducer of Pathological Iron Deposition in Human CNS Disorders?
11:30 AM - 02:30 PM Abstract 080 - Linkage Disequilibrium Analysis of ASPM in Cases with Dementia and Controls
11:30 AM - 02:30 PM Abstract 081 - Isoform-Specific Effects of Apolipoprotein E on Secretion of Inflammatory Mediators in Adult Rat Microglia
11:30 AM - 02:30 PM Abstract 082 - Clinical-Pathological Correlation of Distinct Biochemical Forms of A[beta] in Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 083 - Mitochondrial Damage and Corpora Amylacea Formation in Mild Cognitive Impairment
11:30 AM - 02:30 PM Abstract 084 - The Neuronal [alpha]3-Na+,K+- ATPase Receptor: A New Therapeutic Target for Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 085 - Class II MHC HLA-DRB1 Alleles Influence the Age of Onset, and Disease Course in African American Multiple Sclerosis Patients
11:30 AM - 02:30 PM Abstract 086 - ABC-Transporter Gene-Polymorphisms as Potential Predictors of Therapeutic Efficacy of Mitoxantrone in MS
11:30 AM - 02:30 PM Abstract 087 - Gene Expression Profile of Cerebrospinal Fluid Mononuclear Cells in Oligoclonal Band Positive and Oligoclonal Band Negative Multiple Sclerosis Patients at Early Stage of Disease
11:30 AM - 02:30 PM Abstract 088 - Leukoencephalopathy in Adult Polyglucosan Body Disease (APBD)
11:30 AM - 02:30 PM Abstract 089 - Regulation of p53 Expression in PBMC by Beta Interferon in Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 090 - Gene Expression Signature Predicts Clinical Outcome in Relapsing-Remitting Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 092 - The Role of Genetic Polymorphism in the Type III Promoter of the Major Histocompatibility Complex Class II Transactivator Gene in Susceptibility to Multiple Sclerosis.
11:30 AM - 02:30 PM Abstract 093 - Gene Expression Profile and Clinical Outcome in Relapsing-Remitting Multiple Sclerosis Patients Treated with Glatiramer Acetate
11:30 AM - 02:30 PM Abstract 094 - The Relationship of Inflammatory Markers with Clinical Parameters in Multiple Sclerosis and Post-Poliomyelitis Syndrome
11:30 AM - 02:30 PM Abstract 095 - Cellular and Molecular Analysis of SVZ-Resident Neural Stem Cells in Mice Affected by Chronic Experimental Autoimmune Encephalomyelitis (EAE)
11:30 AM - 02:30 PM Abstract 096 - Interactions between CD4+ T Cells and MHC Class II+ APCs Occur in the Subarachnoid Space Early during the Development of Experimental Autoimmune Encephalomyelitis (EAE)
11:30 AM - 02:30 PM Abstract 097 - Presence of Glatiramer Acetate (GA)-Specific T Cells in the Cerebrospinal Fluid of GA-Treated MS Patients and GA-T Cell Transferred EAE Mice Producing TH2 Cytokines and Neurotrophic Factors
11:30 AM - 02:30 PM Abstract 098 - Regulation of Sonic Hedgehog-Gli Signaling in Neural Stem Cells during Experimental Autoimmune Encephalomyelitis
11:30 AM - 02:30 PM Abstract 099 - Cortical Multiple Sclerosis-Like Lesions with Persistent Microglial Activation and Neuronal Dysfunction in EAE
11:30 AM - 02:30 PM Abstract 100 - Reversal of Chronic EAE and Alteration of Macrophage Function by Symadex[trade] (C-1311)
11:30 AM - 02:30 PM Abstract 101 - CNS Mediated Effects of FTY720 (Fingolimod) in EAE
11:30 AM - 02:30 PM Abstract 102 - Myeloid Suppressor Cells in Experimental Autoimmune Encephalomyelitis
11:30 AM - 02:30 PM Abstract 103 - Ingested (Oral) SIRS Peptide 1-21 Inhibits Active and Adoptive EAE
11:30 AM - 02:30 PM Abstract 104 - Nasal MOG (35-55) Reduces Disease Progression and Axonal Damage in a Model of Chronic Progressive EAE
11:30 AM - 02:30 PM Abstract 105 - Differential Effects of Estrogen Receptor (ER)[alpha] Versus ER[beta] Ligand Treatment: Anti-Inflammatory Versus Directly Neuroprotective
11:30 AM - 02:30 PM Abstract 106 - Prevention of Demyelination and Possible Remyelinationby Glatiramer Acetate in EAE Mice Visualized by the Novel Wet SEM Technology and Immunohistochemistry
11:30 AM - 02:30 PM Abstract 107 - SDF-1 alpha Expression Marks Foci of Transient and Regulated Atypical Neural Stem Cell Niches in Relapsing Remitting Experimental Autoimmune Encephalomyelitis (EAE)
11:30 AM - 02:30 PM Abstract 108 - Fullerene (ABS-75) Treatment Reduces Disease Progression and Axonal Loss in MOG-Induced Progressive EAE in NOD Mice
11:30 AM - 02:30 PM Abstract 109 - PD-L1 Has Differential Effects on the Regulation of Th1 and ThIL-17 Function within the CNS
11:30 AM - 02:30 PM Abstract 110 - Glatiramer Acetate Reduces Toll-Like Receptor 9 Expression in EAE Induced Mice
11:30 AM - 02:30 PM Abstract 112 - CD14-Deficiency Ameliorates Experimental Autoimmune Encephalomyelitis Via TLR-4 Independent Mechanisms
11:30 AM - 02:30 PM Abstract 113 - Drug Delivery of Minocycline by Liposomes Is Effective in Ameliorating in Experimental Autoimmune Encephalomyelitis
11:30 AM - 02:30 PM Abstract 114 - Tetracycline-Regulated Delivery of IFN-Beta Enhances Therapeutic Potential in a Mouse Model of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 116 - Pharmacoproteomics at the Bedside: A Study of tPA Treatment in Acute Ischemic Stroke Patients
11:30 AM - 02:30 PM Abstract 117 - The Significance of Serum Gamma-Glutamyltransferase in Acute Cerebral Infarction
11:30 AM - 02:30 PM Abstract 118 - S-100B Protein Predicts the Early Recanalization of the Acute Middle Cerebral Artery Occlusion
11:30 AM - 02:30 PM Abstract 119 - CADASIL: Molecular Analysis of Aberrant Gene Expression in the Brain
11:30 AM - 02:30 PM Abstract 120 - The PDE4D Genetic Effect on Early-Onset Ischemic Stroke among Normotensive Patients
11:30 AM - 02:30 PM Abstract 121 - Genetics of Ischaemic Stroke among Non-Caucasians: A Meta-Analysis of Eight Candidate Genes Involving Approximately 32,500 Subjects
11:30 AM - 02:30 PM Abstract 122 - The Lower Number of Microbleedings in Patients with Hypertensive Intracerebral Hemorrhage Is Associated with C677T MTHFR TT Mutant Genotype.
11:30 AM - 02:30 PM Abstract 123 - Monitoring Platelet Inhibition by Clopidogrel and Ticlopidine Using Rapid Platelet Function Assay in Patients with Ischemic Stroke
11:30 AM - 02:30 PM Abstract 124 - Aspirin Insensitivity Not Detected by Thromboelastography in Most Stroke Patients
11:30 AM - 02:30 PM Abstract 125 - External Validation of a Scheme To Identify Persons for Asymptomatic Carotid Artery Stenosis Screening
11:30 AM - 02:30 PM Abstract 126 - A Concurrent Comparison of Primary Angioplasty and Primary Stent Placement in High-Risk Patients with Symptomatic Intracranial Stenosis
11:30 AM - 02:30 PM Abstract 127 - The Safety of Carotid Artery Stenting in Pre-Occlusive Lesions: The Impact of the "String" Sign.
11:30 AM - 02:30 PM Abstract 128 - Impact of Age on Periprocedural Outcomes of Carotid Artery Stenting in Symptomatic Patients
11:30 AM - 02:30 PM Abstract 129 - Arterial Stiffness Is Associated with Intracranial Stenosis among Ischemic Stroke Patients
11:30 AM - 02:30 PM Abstract 130 - A Novel Treatment of Intracranial and Vertebral Arterial Stenoses with Balloon Dilatation and a Specifically Designed Self-Expanding Wingspan Intracranial Atherosclerotic Stent
11:30 AM - 02:30 PM Abstract 131 - Non-Invasive Detection of Diffuse Intracranial Disease
11:30 AM - 02:30 PM Abstract 132 - Evaluation of Mast Cells in Atherosclerotic Lesions in Endarterectomy Specimens
11:30 AM - 02:30 PM Abstract 133 - Carotid Stent Placement Versus Carotid Endarterectomy for Treatment of High Surgical Risk Patients with Carotid Stenosis: A Pooled-Analysis of 3282 Patients
11:30 AM - 02:30 PM Abstract 134 - Elevated Plasma Homocysteine, a Risk Factor of White Matter Ischemic Lesions, Was Not Related with Atherosclerotic Steno-Occlusive Lesions in Ischemic Stroke Patients
11:30 AM - 02:30 PM Abstract 135 - Isolated Leg Rest Tremor over Three Decades Caused by a Novel Parkin Mutation
11:30 AM - 02:30 PM Abstract 136 - Novel Mutation in PINK1 Gene Causing Autosomal Recessive Parkinsonism in a Large Tunisian Family
11:30 AM - 02:30 PM Abstract 137 - Three Parkin Mutations in a Family with Parkinson's Disease
11:30 AM - 02:30 PM Abstract 138 - Clinical Expression of the LRRK2 G2019S Mutation in Ashkenazi Jews
11:30 AM - 02:30 PM Abstract 139 - LRRK2 Is Not a Significant Cause of Parkinson's Disease in the French-Canadian Founder Population
11:30 AM - 02:30 PM Abstract 140 - Exclusion of the G2019S LRRK2 Mutation in Sporadic Parkinson's Disease in Arabic Villages in Israel: A Door-to-Door Prevalence Study
11:30 AM - 02:30 PM Abstract 141 - Joint Effects of Alpha-Synuclein and Beta-Synuclein Genes in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 142 - Multitracer Positron Emission Tomographic Analysis of Progression of Presynaptic Dopaminergic Dysfunction in a LRRK2 Kindred
11:30 AM - 02:30 PM Abstract 143 - Analysis of PARK Gene Mutations in Early-Onset Parkinson's Disease Korean Cohort
11:30 AM - 02:30 PM Abstract 144 - Electrophysiological Studies in Inherited Myoclonus-Dystonia
11:30 AM - 02:30 PM Abstract 145 - Restless Legs Syndrome in Uremic Patients in Brazil: Prevalence, Biochemical Findings and Renal Diseases
11:30 AM - 02:30 PM Abstract 146 - Impaired Associative Plasticity in Restless Legs Syndrome
11:30 AM - 02:30 PM Abstract 147 - Treatment of Tibialis Anterior Muscles with Botulinum Toxin A Can Relieve the Symptoms of Restless Legs Syndrome
11:30 AM - 02:30 PM Abstract 148 - Correlation of the SleepMed Insomnia Index (SMI) with the International Restless Legs Scale Score (IRLSS) in Moderately Severe Restless Legs Syndrome
11:30 AM - 02:30 PM Abstract 149 - Painful Legs Moving Toes: Clinical and Electrophysiological Observations
11:30 AM - 02:30 PM Abstract 150 - New Locus for Benign Hereditary Chorea with Adult-Onset Maps to Chromosome 8q22.2-q23.3
11:30 AM - 02:30 PM Abstract 151 - Interference Effect of Motor and Cognitive Dual-Task on Gait in Huntington's Disease
11:30 AM - 02:30 PM Abstract 152 - Grip-Force Variability in Asymptomatic Carriers of the Huntington Gene - A Biomarker for Presymptomatic Clinical Studies?
11:30 AM - 02:30 PM Abstract 153 - Volumetric Brain Changes in Huntington Disease to Search New Biomarkers
11:30 AM - 02:30 PM Abstract 154 - Manganese Toxicity Due to Oral Ingestion as an Acne Treatment
Faculty Disclosures
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Susan B. Bressman, MD, FAAN The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.
Timothy C. Hain, MD No disclosure on file
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Vern C. Juel, MD, FAAN Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Juel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. The institution of Dr. Juel has received research support from argenx. The institution of Dr. Juel has received research support from Alexion. The institution of Dr. Juel has received research support from Janssen. The institution of Dr. Juel has received research support from NIH Rare Diseases Network.
Gil I. Wolfe, MD, FAAN Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Anthony E. Lang, MD, FAAN Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Anthony A. Amato, MD, FAAN Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Caballeta. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Amato has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viridian Therapeutics. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medpace. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Amato has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for legal firms. The institution of Dr. Amato has received research support from NIH. Dr. Amato has received publishing royalties from a publication relating to health care.
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
David F. Black, MD No disclosure on file
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Ted M. Burns, MD Dr. Burns has nothing to disclose.
Thomas C. Chelimsky, MD Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Proctor & Gamble. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Various Legal Firms. Dr. Chelimsky has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Legal Firms. Dr. Chelimsky has received stock or an ownership interest from PainSTakers, LLC. The institution of Dr. Chelimsky has received research support from NIDDK. The institution of Dr. Chelimsky has received research support from Advancing a Healthier Wisconsin.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.
Michele Tagliati, MD, FAAN Dr. Tagliati has received publishing royalties from a publication relating to health care.
Marinos C. Dalakas, MD, FAAN Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink.
Richard J. Barohn, MD, FAAN Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Alex B. Chebl, MD No disclosure on file
Donald B. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant Health Services. Dr. Sanders has received personal compensation in the range of $0-$499 for serving as a Consultant for Cabaletta BIO. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kashiv Biosciences. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen RnD. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-aventis. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VielaBio. Dr. Sanders has received publishing royalties from a publication relating to health care.
Janice M. Massey, MD, FAAN Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenix. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance Therapeutics. Dr. Massey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. The institution of Dr. Massey has received research support from Revance .
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
Steven Vernino, MD, PhD, FAAN Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Eelco F. Wijdicks, MD, FAAN Dr. Wijdicks has received publishing royalties from a publication relating to health care.
Nutan Sharma, MD, PhD, FAAN Dr. Sharma has nothing to disclose.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Richard M. Ransohoff, MD Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Takayoshi Shimohata, MD, FAAN Dr. Shimohata has nothing to disclose.
Bahman Jabbari, MD, FAAN Dr. Jabbari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jabbari has received publishing royalties from a publication relating to health care.
Lawrence H. Phillips II, MD, FAAN No disclosure on file
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Amer Alshekhlee, MD No disclosure on file
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Tahseen Mozaffar, MD, FAAN Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Emmanuelle Pourcher, MD No disclosure on file
Suhayl S. Dhib-Jalbut, MD, FAAN No disclosure on file
Maria V. Alvarez, MD No disclosure on file
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Lloyd H. Kasper, MD No disclosure on file
Omar A. Khan, MD, PhD No disclosure on file
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Lindsey L. Lair, MD, FAAN Dr. Lair has received personal compensation for serving as an employee of Biohaven. An immediate family member of Dr. Lair has received personal compensation for serving as an employee of PPD/Thermo Fisher Scientific. Dr. Lair has stock in Biohaven. An immediate family member of Dr. Lair has stock in PPD/Thermo Fisher Scientific. Dr. Lair has a non-compensated relationship as a Board Member with NY State Neurological Society that is relevant to AAN interests or activities.
Agustin Legido, MD, PhD, MBA No disclosure on file
Sasha Zivkovic, MD, FAAN Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Zivkovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics. Dr. Zivkovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical services.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Ignacio Valencia, MD No disclosure on file
Ann L. Hunt, DO No disclosure on file
William D. Gaillard, MD The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Nir Giladi, MD, FAAN Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Karin B. Nelson, MD No disclosure on file
Jessica Carpenter, MD Dr. Carpenter has nothing to disclose.
Janet C. Lam, MD No disclosure on file
Marian J. Kolodgie, RN No disclosure on file
Steven L. Weinstein, MD No disclosure on file
Taeun Chang, MD No disclosure on file
Tammy Tsuchida, MD, PhD The institution of Dr. Tsuchida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon Pharmaceuticals Inc. The institution of Dr. Tsuchida has received research support from Xenon Pharmaceuticals Inc.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Jie-Yuan Li, MD No disclosure on file
Pramod K. Pal, MD, MBBS, DNB, DM No disclosure on file
Jason Brandt, PhD No disclosure on file
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Masatoyo Nishizawa, MD No disclosure on file
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
April L. McVey, MD No disclosure on file
Yaakov Stern, PhD Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Stern has received intellectual property interests from a discovery or technology relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Bradley T. Hyman, MD, PhD An immediate family member of Dr. Hyman has received personal compensation for serving as an employee of novartis. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for dewpoint. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for abbvie. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvinas. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for avrobio. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dept of Justice. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cell Signalling. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Hyman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for sanofi. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vigil. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for voyager. Dr. Hyman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Hyman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for dept of justice. Dr. Hyman has stock in dewpoint. The institution of Dr. Hyman has received research support from nih. The institution of Dr. Hyman has received research support from JPB. The institution of Dr. Hyman has received research support from Cure Alz Fund. The institution of Dr. Hyman has received research support from Tau consortium. The institution of Dr. Hyman has received research support from abbvie. The institution of Dr. Hyman has received research support from BMS.
No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Mark Dolev Dolgopiat, MD No disclosure on file
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
Ahmed E. El-Gengaihy, MD No disclosure on file
Ammar Al Kawi, MD, FAAN Dr. Al Kawi has nothing to disclose.
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Lindsay A. Farrer, MD No disclosure on file
Robert P. Friedland, MD, FAAN No disclosure on file
Alexander Lossos, MD Dr. Lossos has nothing to disclose.
Yacov Balash, MD No disclosure on file
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Tarannum Lateef, MD No disclosure on file
Luis A. Chui, MD No disclosure on file
Yunxia Wang, MD, FAAN Dr. Wang has nothing to disclose.
Rosana H. Scola, MD Dr. Scola has nothing to disclose.
William Martens William Martens has nothing to disclose.
James E. Hilbert, MS Mr. Hilbert has nothing to disclose.
Richard T. Moxley III, MD, FAAN Dr. Moxley has nothing to disclose.
Bryan Traynor, MD The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Wassim Elyaman, PhD Dr. Elyaman has nothing to disclose.
Jaime Imitola, MD, FAAN The institution of Dr. Imitola has received research support from Genentech. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.
John A. Hardy, PhD No disclosure on file
Francois Grand-Maison, MD Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Kyung-Hee Cho, MD No disclosure on file
Lawrence K. Wong No disclosure on file
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
A-Hyun Cho, MD, PhD No disclosure on file
Mohammad Salajegheh, MD, FAAN Dr. Salajegheh has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with US Department of Veterans Affairs. Dr. Salajegheh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CRICO.
Ralf Reilmann, MD, FAAN The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for uniQure. The institution of Dr. Reilmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WAVE. Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WAVE. The institution of Dr. Reilmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IOS-Press. The institution of Dr. Reilmann has received research support from European Union. Dr. Reilmann has a non-compensated relationship as a Executive Committee Member with Huntington Study Group that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Member of Executive Committee with European Huntington Disease Network that is relevant to AAN interests or activities. Dr. Reilmann has a non-compensated relationship as a Co-Chair Task Force on Huntington Disease with Movement Disorders Socitey that is relevant to AAN interests or activities.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
David Robertson, MD No disclosure on file
Annette Janus, MD No disclosure on file
Steven A. Greenberg, MD Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abcuro, Inc.. Dr. Greenberg has stock in Abcuro. Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care.
Vanja C. Douglas, MD, FAAN Dr. Douglas has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various legal firms. Dr. Douglas has received publishing royalties from a publication relating to health care. Dr. Douglas has received publishing royalties from a publication relating to health care.
John Vissing, MD Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Prof. Vissing has received personal compensation in the range of $0-$499 for serving as a Consultant for Denali Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Italfarmaco. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NMD Pharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson & Johnson (Janssen). Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from Avidity. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from Roche. The institution of Prof. Vissing has received research support from AnnJi.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Ali Samii, MD, FRCP Dr. Samii has nothing to disclose.
Robert L. Sufit, MD No disclosure on file
Alida F. Griffith, MD No disclosure on file
Goran Rakocevic, MD, FAAN Dr. Rakocevic has nothing to disclose.
Aissatou Haman No disclosure on file
Haydeh Payami, PhD No disclosure on file
John R. Lynch, MD No disclosure on file
Viktor Szeder, MD, PhD Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
Dhruvil J. Pandya, MD No disclosure on file
Thomas J. Wolfe, MD No disclosure on file
Brian-Fred M. Fitzsimmons, MD No disclosure on file
Osama O. Zaidat, MD, FAAN Dr. Zaidat has nothing to disclose.
Mitsutoshi Yamamoto, MD, FAAN No disclosure on file
Horacio C. Kaufmann, MD, FAAN Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Theravance. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Kaufmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curasen Therapeutics. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AskBio. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioArctic. Dr. Kaufmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Kaufmann has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Spinger. The institution of Dr. Kaufmann has received research support from Biogen. The institution of Dr. Kaufmann has received research support from Vaxxinity. Dr. Kaufmann has received publishing royalties from a publication relating to health care.
Donald S. Higgins, Jr., MD, FAAN Dr. Higgins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex.
Oded Abramsky, MD, PhD, FAAN No disclosure on file
Beth Wilmot, MS No disclosure on file
Amanda C. Peltier, MD, MS Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Csl Behring. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Peltier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for astrazeneca. Dr. Peltier has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Goldman Ismail. The institution of Dr. Peltier has received research support from NIH. The institution of Dr. Peltier has received research support from CSL Behring.
Ruth D. Nass, MD No disclosure on file
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Mounir Kefi No disclosure on file
Andrei V. Alexandrov, MD The institution of Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovaSignal. Dr. Alexandrov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisc. Dr. Alexandrov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Alexandrov has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Society of Neuroimaging. Dr. Alexandrov has received publishing royalties from a publication relating to health care.
Hsiu-Fen Lin No disclosure on file
Carmelo Rodolico, MD No disclosure on file
Njide Okubadejo, MD, FAAN The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Gillian Devereux No disclosure on file
Vijay K. Sharma, MD No disclosure on file
Mark Groves, MD No disclosure on file
Adib Tanbir No disclosure on file
Daria A. Trojan, MD No disclosure on file
Ricardo D. Rojas Garcia No disclosure on file
Donald S. McCorquodale III, MD, PhD No disclosure on file
Andrew H. Chan, MD No disclosure on file
Bruno Barbiroli, MD No disclosure on file
Wei Song No disclosure on file
Preetha Muthusamy, MD No disclosure on file
Sherry Hsiang-Yi Chou, MD Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to AAN interests or activities.
Stephen J. Karlik, PhD No disclosure on file
Marilyn Albert Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Marilyn Albert has received personal compensation in the range of $500-$4,999 for serving as a Chair with Global Council on Brain Health.
Claudio G. Mazia, MD No disclosure on file
Bibhuti Mishra, MD No disclosure on file
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Janaka K. Seneviratne, MBBS, FRACP No disclosure on file
Gwendolyn C. Claussen, MD No disclosure on file
Valeria A. Sansone, MD Dr. Sansone has nothing to disclose.
Louise R. Rodino-Klapac Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Ridwan Lin, MD, PhD No disclosure on file
Jan Mares, MD Dr. Mares has nothing to disclose.
Jun Goto, MD, PhD No disclosure on file
Elisa Rubino, MD No disclosure on file
Kevin P. Campbell, PhD No disclosure on file
Michael A. Boss, PhD No disclosure on file
Perinne Charles Ignatiew, MD No disclosure on file
Yoshio Bando No disclosure on file
Vicki Shanker, MD, FAAN Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Isabel Illa, MD No disclosure on file
Paulo J. Lorenzoni, MD Dr. Lorenzoni has nothing to disclose.
Vincenzo Rizzo, MD No disclosure on file
Giovanni Meola, MD, FAAN No disclosure on file
Danny Cunic, HB, ScP No disclosure on file
Ian J. Sutton, PhD Dr. Sutton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Sutton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sutton has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Sun U. Kwon, MD No disclosure on file
Arnaud Delval, MD No disclosure on file
Alexandre Basso No disclosure on file
Crystal S. Fo, MD No disclosure on file
George Li, MD Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RemeGen bioscience .
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Bing Zhu No disclosure on file
Meng C. Wong, MBBS, MMed, FAAN No disclosure on file
Svetlana Lenina No disclosure on file
Sang B. Jeon, MD No disclosure on file
Paolo Girlanda No disclosure on file
Christopher Bever, Jr., MD, MBA, FAAN No disclosure on file
Laura Herbelin No disclosure on file
Paolo Calabresi, MD Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie, Bial, Bayer Schering, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma, Zambon..
Rizma J. Bajwa, MD No disclosure on file
Benjamin Raudabaugh No disclosure on file
Michael Gurevich No disclosure on file
Luc Defebvre No disclosure on file
Alexis Lopez No disclosure on file
Hao Deng, MD No disclosure on file
Ashraf M. Abdou, MD Dr. Abdou has nothing to disclose.
Andrea L. Rosso, MPH No disclosure on file
Mme Rim Amouri, MD No disclosure on file
Juliane Mueller No disclosure on file
Yves L. Lapierre, MD No disclosure on file
Jarlath French-Mullen No disclosure on file
Caterina Tonon No disclosure on file
Fanglin Zhang, MD, PhD No disclosure on file
Pankaj Sharma, MD Dr. Sharma has nothing to disclose.
Robin R. Lincoln Robin R. Lincoln has nothing to disclose.
Tamara M. Pringsheim, MD, FAAN The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Rina Aharoni, PhD No disclosure on file
Norihiro Suzuki No disclosure on file
Xin Ming Shen, PhD, FAAN The institution of Dr. Shen has received research support from NIH. The institution of Dr. Shen has received research support from Myasthenia Gravis Foundation of American.
In Soo Moon, MD No disclosure on file
David S. Younger, MD, DrPH, MPH, MS Dr. Younger has nothing to disclose.
Lan Zhou, MD, PhD The institution of Dr. Zhou has received research support from NIH.
Wei Liu, MD Dr. Liu has nothing to disclose.
Robert H. Baloh, MD, PhD, FAAN Dr. Baloh has received personal compensation for serving as an employee of Roche. Dr. Baloh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Acurastem. Dr. Baloh has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Irell. The institution of Dr. Baloh has received research support from NIH and CIRM.
Christine Tranchant, MD No disclosure on file
Freya Kamel, PhD No disclosure on file
Mahmood S. Eisa, MD, FAAN No disclosure on file
Zarife F. Sahenk, MD, PhD, FAAN Dr. Sahenk has nothing to disclose.
Ching-Kuan Liu, MD No disclosure on file
Vincenzo Bonifati No disclosure on file
Jianhua Yan, PhD No disclosure on file
Deniz Erten-Lyons, MD, FAAN Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.
Onofre Combarros Pascual No disclosure on file
Joseph J. Melvin, DO Dr. Melvin has received personal compensation in the range of $100,000-$499,999 for serving as a Physican with Tower health.
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Aziz Mazarib, MD No disclosure on file
Ronald G. Haller, MD No disclosure on file
Maria Tellez No disclosure on file
Jose' Berciano, MD No disclosure on file
Brett Morrison, MD, PhD No disclosure on file
Leah Gaedeke, MSN, FNP-BC No disclosure on file
G. P. Gliebus, MD, FAAN Dr. Gliebus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai.
Gerard Schellenberg, PhD No disclosure on file
Daniel Reich, MD, PhD Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities.
Timothy Lesnick No disclosure on file
Mitsuru Kawai, MD No disclosure on file
Michael I. Shevell, MD, FAAN Dr. Shevell has nothing to disclose.
Daniel Sanak No disclosure on file
Ferdinando Buonanno, MD No disclosure on file
Shin J. Oh, MD, FAAN No disclosure on file
Laurie J. Ozelius, PhD The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Claudia Testa, MD, PhD Dr. Testa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for uniQure. Dr. Testa has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Tremor Research Group.
John G. Nutt, MD, FAAN No disclosure on file
Osamu Onodera, MD Dr. Onodera has nothing to disclose.
Deborah C. Mash, PhD No disclosure on file
Agustin Oterino Duran, MD No disclosure on file
Claudio Mariani, MD No disclosure on file
Andrew Miller No disclosure on file
Daniela Galimberti, PhD No disclosure on file
Hideshi Kawakami No disclosure on file
Patrizia Amati-Bonneau No disclosure on file
Chad Markert, PhD No disclosure on file
Matthew Farrer, MD No disclosure on file
Juan Carlos Casas, MD No disclosure on file
Dong-wha Kang, MD No disclosure on file
Yannie O. Soo, MD No disclosure on file
Michal Kral No disclosure on file
Jacek Rozniecki, MD, PhD, DSc No disclosure on file
Yuesong Gong No disclosure on file
Massimiliano Calabrese, MD No disclosure on file
Alain Destee, MD, PhD No disclosure on file
Izumi Kawachi, MD, PhD Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Mochida Pharmaceutical CO., LTD.. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving as a Consultant for Euroimmune. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Chugai Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis Pharma. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma. Dr. Kawachi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Argenx. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Kawachi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi-Sankyo. Dr. Kawachi has received research support from JSPS KAKENHI. Dr. Kawachi has received research support from MHLW Research Program on Rare and Intractable Diseases. Dr. Kawachi has received research support from Japan Kampo Medicine 好色先生 Foundation.
Meziane Guerch, MD No disclosure on file
Hillel Zukor No disclosure on file
Masato Kanazawa, MD, FAAN Dr. Kanazawa has nothing to disclose.
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Dora Yearout The institution of Dora Yearout has received research support from Veterans Affairs, NIH, and MJFF reserach grants.
Neus Tellez No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Ronan Walsh, MD No disclosure on file
Anna Mazzeo, MD Dr. Mazzeo has nothing to disclose.
Angela Abicht, MD No disclosure on file
Khyung-Pil Park No disclosure on file
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Lineu C. Werneck, MD No disclosure on file
Kathryn R. Wagner, MD, PhD Dr. Wagner has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Wagner has stock in F. Hoffmann-La Roche.
Soo J. Lee, MD No disclosure on file
Claudia S. Kay, MD Dr. Kay has nothing to disclose.
Jean-Baptiste Riviere, MSc No disclosure on file
Federica Ranzato No disclosure on file
Andrea Martinuzzi, MD, PhD, FAAN No disclosure on file
Ferdinando Squitieri, MD, PhD No disclosure on file
Olimpia Musumeci No disclosure on file
Lorenzo Pinessi, MD No disclosure on file
Tatiana Mihalova, MD MRCP No disclosure on file
Henrik Zetterberg Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Jerome Franques, MD No disclosure on file
Steffi Grey No disclosure on file
Hui M. Chang, MBBS No disclosure on file
Thomas O. Crawford, MD Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Rodica Elena Petrea, MD Dr. Petrea has nothing to disclose.
Paola Sarchielli No disclosure on file
Teepu Siddique, MD, FAAN No disclosure on file
J A. Urtizberea, MD No disclosure on file
Luigi M. Serlenga No disclosure on file
Stephanie Pinz No disclosure on file
Andrei Voustianiouk No disclosure on file
Divya S. Khurana, MD No disclosure on file
MingMing Ning, MD No disclosure on file
Audrey Strongosky No disclosure on file
Clive P. Hawkins, MD No disclosure on file
Soo J. Yoon No disclosure on file
Jacob Vaya No disclosure on file
Shannon McWeeney No disclosure on file
Wei Hu, MD, PhD No disclosure on file
Jong-Un Chun, MD No disclosure on file
Seema K. Tiwari-Woodruff, PhD No disclosure on file
Rosalia C. Silvestri-Hobson, MD No disclosure on file
Shuang Chen, MD No disclosure on file
Ronald Schondorf, MD No disclosure on file
Mikael Mazighi No disclosure on file
Marcel Hungs, MD, PhD, FAAN No disclosure on file
Christopher Shilling, MS No disclosure on file
Philippe Derambure No disclosure on file
Pierluigi Bertora No disclosure on file
Corrado Angelini, MD, FAAN Dr. Angelini has nothing to disclose.
Martin K. Childers, DO, PhD No disclosure on file
Raphael A. Carandang, MD, FAAN Dr. Carandang has nothing to disclose.
Ben M. Illigens, MD Dr. Illigens has received personal compensation for serving as an employee of Target Health. Dr. Illigens has received personal compensation for serving as an employee of BC Platforms. Dr. Illigens has received personal compensation for serving as an employee of NOVA Discovery. Dr. Illigens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RDP Pharma. Dr. Illigens has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Biomind Labs. Dr. Illigens has a non-compensated relationship as a Director with Partners for Patients that is relevant to AAN interests or activities.
Lisa M. Hickey No disclosure on file
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Lev Goldfarb, MD No disclosure on file
Stephen P. Salloway, MD, MS Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EISAI. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NovoNordisk. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prothena. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Salloway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurophet. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kisbee. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CognitionRX. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Salloway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Salloway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck.
Roberto Massa, MD No disclosure on file
Fanny Mochel, MD Dr. Mochel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx.
Anis Mir No disclosure on file
Jonathan M. Goldstein, MD No disclosure on file
Hauke Schneider, MD The institution of Dr. Schneider has received research support from Medical Faculty, University of Augsburg, Germany.
Spyridon Papapetropoulos, MD, PhD Dr. Papapetropoulos has received personal compensation for serving as an employee of Vigil Neuroscience . Dr. Papapetropoulos has received personal compensation for serving as an employee of Bionomics Ltd. Dr. Papapetropoulos has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Lipocine Inc. Dr. Papapetropoulos has stock in Vigil Neuroscience. Dr. Papapetropoulos has stock in Lipocine. Dr. Papapetropoulos has stock in Bionomics Ltd.
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
Jose L. Vega, MD, PhD No disclosure on file
Joshua R. Steinerman, MD Dr. Steinerman has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. Steinerman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Click Therapeutics. Dr. Steinerman has received stock or an ownership interest from Greenwich Biosciences. Dr. Steinerman has received stock or an ownership interest from Click Therapeutics. Dr. Steinerman has received intellectual property interests from a discovery or technology relating to health care.
Vidar Stenset, MD No disclosure on file
Jose Ignacio Mateo Fernandez No disclosure on file
Ichizo Nishino, MD, PhD, FAAN The institution of Dr. Nishino has received research support from AMED.
Demetrius M. Maraganore, MD, FAAN Dr. Maraganore has nothing to disclose.
Tiziana Mongini, MD No disclosure on file
Dominique Bonneau No disclosure on file
Jennifer Schymick No disclosure on file
Jo Anne Turner, APRN No disclosure on file
David Skoloudik, MD, PhD No disclosure on file
Pierre Krystkowiak, MD, PhD No disclosure on file
Joohi Jimenez Shahed, MD, FAAN Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Treefrog. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RebrAIn. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. The institution of Dr. Jimenez Shahed has received research support from Ono Pharmaceuticals. The institution of Dr. Jimenez Shahed has received research support from BlueRock. The institution of Dr. Jimenez Shahed has received research support from Neuron23. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with 好色先生. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation.
Michel Fardeau, MD No disclosure on file
Lindsay Puckett No disclosure on file
Alexandra Durr, MD The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Christophe Verny No disclosure on file
Sharon P. Nations, MD, FAAN No disclosure on file
Roger M. Kurlan, MD, FAAN No disclosure on file
Kensaku Kasuga No disclosure on file
A J. Stoessl, MD, FAAN No disclosure on file
Sridar Narayanan Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Tapas K. Makar, PhD No disclosure on file
Letizia Maria Cupini, MD No disclosure on file
Eloy Rodriguez-Rodriguez Eloy Rodriguez-Rodriguez has nothing to disclose.
Chantal Poulin, MD, FRCPC No disclosure on file
Wei-Dong Le, MD, PhD No disclosure on file
Stefan Bohlen, MD No disclosure on file
Claudio Colonnese, MS No disclosure on file
David A. Brenner, MD No disclosure on file
Marcos R. De Freitas, MD, PhD No disclosure on file
Jong S. Kim, MD, PhD No disclosure on file
Innocenzo Rainero, MD, PhD No disclosure on file
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Nam Hee Kim, MD No disclosure on file
Jean-Francois Gagnon The institution of Jean-Francois Gagnon has received research support from Canadian Institute of Health Research. The institution of Jean-Francois Gagnon has received research support from Canada Research Chair. The institution of Jean-Francois Gagnon has received research support from National Institutes of Health.
Shalini Mukherjee, PhD No disclosure on file
Antonio Toscano, MD Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Luciano Rinaldi No disclosure on file
David Beeson, PhD No disclosure on file
Patricia L. Kramer, PhD No disclosure on file
Michael C. Irizarry, MD Dr. Irizarry has received personal compensation for serving as an employee of Eisai, Inc..
Bruno Coutinho, MD No disclosure on file
Sea-Mi Park, PhD No disclosure on file
Nikolaos C. Grigoriadis, MD, PhD No disclosure on file
Leif Gjerstad, MD, PhD, FAAN No disclosure on file
Hayrunnisa Bolay Belen No disclosure on file
Mamatha Pasnoor, MD, FAAN Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen.
Eng Lo, MD Eng Lo, MD has nothing to disclose.
Marco Prinz No disclosure on file
David Magalashvili, MD No disclosure on file
Jill S. Goldman, MS MPhil CGC No disclosure on file
Jorge Oksenberg, MD No disclosure on file
Jennifer Walker, MD No disclosure on file
Paolo Gallo, MD Dr. Gallo has nothing to disclose.
Frederic Dubas, PrMD No disclosure on file
John R. Crawford, MD Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Reibeck medical consulting.
Hanns Lochmuller, MD, FAAN Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CCRM. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Canada Inc. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KYE Pharma. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lochmuller has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satellos. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi US. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Precision. Dr. Lochmuller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Sophie Carre No disclosure on file
Marc Malkoff, MD, FAAN Dr. Malkoff has nothing to disclose.
Gonzalo Revuelta, DO The institution of Dr. Revuelta has received research support from NIH.
Rivka Inzelberg, MD No disclosure on file
Diana Miller, MD No disclosure on file
Hanna Rosenmann No disclosure on file
Juan J. Vilchez Padilla, MD Dr. Vilchez Padilla has nothing to disclose.
Steven L. Hoover, MD No disclosure on file
Jon Infante Ceberio No disclosure on file
Giovanna Vaula, MD No disclosure on file
K. Reed Clark, PhD No disclosure on file
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Monica Sethi No disclosure on file
Paul Magda, DO Dr. Magda has nothing to disclose.
Diana Richardson, MD No disclosure on file
Laura Brighina, MD No disclosure on file
Osvaldo J. Nascimento, MD, PhD, FAAN Dr. Nascimento has nothing to disclose.
Stine Rasmussen No disclosure on file
Georgios Tsivgoulis, MD, FAAN Dr. Tsivgoulis has nothing to disclose.
Jayawant N. Mandrekar, PhD Dr. Mandrekar has nothing to disclose.
Adele Salin-Cantegrel No disclosure on file
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Sheng-Han Kuo, MD, FAAN Dr. Kuo has nothing to disclose.
Jonathan Haines, MD No disclosure on file
Steven P. Novella, MD No disclosure on file
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Charles Torres-Chae No disclosure on file
Anna Schubart No disclosure on file
Hauke Schmidt No disclosure on file
Raghavan Raju, PhD No disclosure on file
Nandhagopal Ramachandiran, MBBS, DM, FRCP, FAAN, FANA, FAAN Dr. Ramachandiran has nothing to disclose.
Christopher H. Gibbons, MD, FAAN Dr. Gibbons has received personal compensation for serving as an employee of CND Life Sciences. Dr. Gibbons has or had stock in CND Life Sciences.Dr. Gibbons has received publishing royalties from a publication relating to health care.
Amanda L. Deligtisch, MD, FAAN No disclosure on file
Nina Barisic, MD, PhD The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving as a Consultant for roche. The institution of Dr. Barisic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis.
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Hyman M. Schipper, MD, PhD, FAAN No disclosure on file
Cyrus P. Zabetian, MD The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Rhonda Voskuhl, MD Dr. Voskuhl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CleopatraRX. Dr. Voskuhl has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for CleopatraRX. Dr. Voskuhl has or had stock in CleopatraRX. The institution of Dr. Voskuhl has received research support from NIH. The institution of Dr. Voskuhl has received research support from Conrad N Hilton Foundation. Dr. Voskuhl has received intellectual property interests from a discovery or technology relating to health care.
Jesus Pradas, MD No disclosure on file
Jaya Trivedi, MD, FAAN The institution of Dr. Trivedi has received research support from Avidity.
John W. Roberts, MD No disclosure on file
Melina Jones, PhD No disclosure on file
Kwang W. Lee, MD No disclosure on file
Eduard Gallardo No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Han Jin Cho No disclosure on file
W. B. Burnette, MD No disclosure on file
Michael R. Rose, MD No disclosure on file
Mustafa A. Salih, MD, FAAN No disclosure on file
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Kenju Hara, MD No disclosure on file
Ha-Sup Song No disclosure on file
Faycal Hentati, MD No disclosure on file
Mary M. Ransom, MD No disclosure on file
Michael Kruer, MD Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PTC Therapeutics. The institution of Dr. Kruer has received research support from NIH NINDs. The institution of Dr. Kruer has received research support from Medtronic . Dr. Kruer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with NHRSA.
H. Huntley Hardison, MD, FAAN No disclosure on file
Elio A. Scarpini, MD No disclosure on file
Gianvito Martino, MD Dr. Martino has nothing to disclose.
Paula R. Clemens, MD The institution of Dr. Clemens has received research support from NS Pharma. The institution of Dr. Clemens has received research support from ReveraGen. The institution of Dr. Clemens has received research support from Amicus. The institution of Dr. Clemens has received research support from Sanofi. The institution of Dr. Clemens has received research support from Spark. The institution of Dr. Clemens has received research support from NIH. The institution of Dr. Clemens has received research support from MDA. The institution of Dr. Clemens has received research support from FDA.
Sebastian Koch, MD Dr. Koch has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple Legal Matters. Dr. Koch has received stock or an ownership interest from Cerepeutics. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care. Dr. Koch has received intellectual property interests from a discovery or technology relating to health care.
Phyllis Faust Phyllis Faust has nothing to disclose.
Daniel J. Licht, MD No disclosure on file
Amer Malik, MD Dr. Malik has nothing to disclose.
Jean-Martin Boulanger, MD, FRCPC No disclosure on file
Silke Schmidt, PhD No disclosure on file
Isabel Arrillaga-Romany, MD Dr. Arrillaga-Romany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. The institution of Dr. Arrillaga-Romany has received research support from Astex Pharmaceuticals. The institution of Dr. Arrillaga-Romany has received research support from Gsk.
Aiesha Ahmed, MD, MBA, FAAN Dr. Ahmed has stock in Doximity.
Gabriel Posadas Zuniga, MD No disclosure on file
Stephen Moster No disclosure on file
Jim Wu No disclosure on file
Hasan Askari, MD No disclosure on file
Maria C. Fernandez, MD Dr. Fernandez has nothing to disclose.
Balaji Krishnaiah, MD, FAAN Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACP. Dr. Krishnaiah has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Merck Manual. Dr. Krishnaiah has received publishing royalties from a publication relating to health care.
Sanaz Karimi, MD No disclosure on file
Elizabeth M. Wells, MD The institution of Dr. Wells has received research support from National Institute of Allergy and Infectious Diseases.
Raquel Farias-Moeller, MD Dr. Farias-Moeller has nothing to disclose.
Diana Mnatsakanova, MD Dr. Mnatsakanova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. Dr. Mnatsakanova has received research support from Mitsubishi .
Robert C. Burger, MD No disclosure on file
Angel Golimstok No disclosure on file
Ning Wu, MD No disclosure on file
Alejandro Vargas, MD, MS, FAAN Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Katherine Fu, MD Dr. Fu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生: Neurology Journal . Dr. Fu has received research support from 好色先生. Dr. Fu has received personal compensation in the range of $0-$499 for serving as a Edmond J. Safra Fellowship Reviewer with The Michael J. Fox Foundation.
Stephen C. Ross, MD, FAAN Dr. Ross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Highmark.
Steven Xian, MD No disclosure on file
William Mack William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Tatjana Pekmezovic No disclosure on file
Derrece K. Reid, MD No disclosure on file
Juliana Aurencao No disclosure on file
Douglas M. Smith, MD Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pyros Pharma. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher-Smith. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB.
Arastoo Vossough, MD Dr. Vossough has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Syneos Health. Dr. Vossough has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DeepSight. Dr. Vossough has received publishing royalties from a publication relating to health care.
Anza B. Memon, MD, FAAN Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inlightened. Dr. Memon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Memon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutic . The institution of Dr. Memon has received research support from Genentech. The institution of Dr. Memon has received research support from TG Therapeutics.
Natalie C. Wheeler, MD Dr. Wheeler has nothing to disclose.
Victor Fung, MD, MBBS, PhD Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Venkatachalam Mangeshkumar, MD, FAAN No disclosure on file
Karin Woodman, MD Dr. Woodman has nothing to disclose.
Nagbhushan S. Rao, MD, FAAN No disclosure on file
Nuttawan Vongveeranonchai, MD No disclosure on file
Taskin Duman Dr. Duman has nothing to disclose.
Gogi Kumar, MD Dr. Kumar has nothing to disclose.
Daniel P. Cahill, MD, PhD Daniel P. Cahill, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Advise Connect Inspire. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for German Accelerator. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Incephalo. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.
Robert Altman, MD Dr. Altman has nothing to disclose.
Birgit E. Hogl, MD No disclosure on file
Mamta Verma, MD No disclosure on file
Daniel Golan, MD No disclosure on file
Neil Mahant, MD No disclosure on file
Sol T. De Jesus, MD Dr. De Jesus has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic Inc. Dr. De Jesus has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic Inc.
Laura Wilson, MD No disclosure on file
Irina A. Anselm, MD Dr. Anselm has nothing to disclose.
Dheeraj Khurana, MD Dr. Khurana has nothing to disclose.
Arnulf H. Koeppen, MD, FAAN Dr. Koeppen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Koeppen has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for North Carolina.
Alex Desautels, MD, PhD No disclosure on file
Alejandra D. Martinez, MD No disclosure on file
Anne D. Yacoub, MD Dr. Yacoub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie.
Joo Yeon Nam, MD No disclosure on file
Sergio Lindembaum No disclosure on file
Hyun-Sik Yang, MD Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axon advisors. The institution of Dr. Yang has received research support from National Institutes of Health. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a study section member with National Institutes of Health.
Rocio Hernandez Clares, MD, PhD No disclosure on file
Lance Rodan, MD No disclosure on file
Florence C. Chang, MD No disclosure on file
Cecilia Vidal, MD No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Marisela E. Dy-Hollins, MD, MSCR, FAAN The institution of Dr. Dy-Hollins has received research support from CNCDP-K12.
Chi-Ying (Roy) Lin, MD, FAAN Dr. Lin has received research support from Texas Alzheimer's Research and Care Consortium (TARCC). Dr. Lin has received research support from CurePSP. Dr. Lin has received research support from Mike Hogg Fund. Dr. Lin has received research support from The Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI). Dr. Lin has a non-compensated relationship as a Secretary with Broadway for Ataxia Foundation (a 501 (c) (3) non-profit organization) that is relevant to AAN interests or activities.
Nicole B. Sur, MD Dr. Sur has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Sur has received research support from Florida Stroke Registry. The institution of Dr. Sur has received research support from Miami CTSI & NIH/NINDS.
James Baier No disclosure on file
Mariane D. Barbosa, MD Dr. Barbosa has nothing to disclose.
Jesse Bastiaens No disclosure on file
Mariana G. Santos, MD No disclosure on file
David Bearden, MD Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bearden has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Bearden has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for law firms.
Minjee Kim, MD The institution of Dr. Kim has received research support from Genentech, Inc.. The institution of Dr. Kim has received research support from National Institute on Aging.
Lori Chibnik No disclosure on file
Colin Wallace No disclosure on file
Maria Cerdan Sanchez No disclosure on file
Esha Khurana No disclosure on file
Maria C. Curbelo No disclosure on file
Mitra Afshari, MD Dr. Afshari has received research support from Consolidated Anti-Aging Foundation . Dr. Afshari has received research support from Parkinson Study Group.
Mohamed A. Sarhan No disclosure on file
Anat Mirelman Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Ester Carreon Guarnizo Ester Carreon Guarnizo has nothing to disclose.
Esther Baranov No disclosure on file
Joana C. Dias, MD No disclosure on file
Debora Szklarz, MD No disclosure on file
Mahesh Chikkannaiah, MD Dr. Chikkannaiah has nothing to disclose.
Hisham Aldhukair, MBBS Dr. Aldhukair has nothing to disclose.
Jonathan R. Galli, MD Dr. Galli has nothing to disclose.
Kaitlin Reilly-Kit, MD Dr. Reilly-Kit has nothing to disclose.
Judith D. Steinberg, MD No disclosure on file
Diego I. Ortega Diaz, Sr. No disclosure on file
Kelsey Bryk, MSc No disclosure on file
Melissa Lee No disclosure on file
Lily Zhou, MD Dr. Zhou has received research support from Canadian Institute of Health Research.
Govind Nair No disclosure on file
Nolan Chen No disclosure on file
Paul Van Donkelaar No disclosure on file
Danielle Lee, MD Dr. Lee has nothing to disclose.
Neil A. Nadkarni, MD No disclosure on file
Ziv Gan-Or, MD, PhD Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuron23. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Gan-Or has received personal compensation in the range of $0-$499 for serving as a Consultant for Lighthouse. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gan-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Handl Therapeutics. Dr. Gan-Or has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial Biotech.
Nathaniel Bendahan, MD No disclosure on file
Kateryna Schwartz No disclosure on file